Skip to main content
. 2020 Aug 26;48(8):0300060520940450. doi: 10.1177/0300060520940450

Table 2.

Incidence of the components of the primary endpoint.

Endpoint All L-arginine/L-citrulline group Placebo group p
Total 23 10 13 n.s.
Death 2 2 0 n.s.
Myocardial infarction 1 1 0 n.s.
Stroke 1 0 1 n.s.
Thromboembolism 14 5 9 n.s.
Angina pectoris 3 0 3 n.s.
Decompensated heart failure 2 2 0 n.s.

n.s., not significant.